about
HPV in oropharyngeal cancer: the basics to know in clinical practiceCrystal ball - 2011Do selective estrogen receptor modulators treat cervical precancer and cancer? Time to pool data from relevant trialsKnowledge of human papillomavirus infection and its prevention among adolescents and parents in the greater Milan area, Northern ItalyHuman papillomavirus e7 oncoprotein transgenic skin develops an enhanced inflammatory response to 2,4-dinitrochlorobenzene by an arginase-1-dependent mechanism.Long-peptide therapeutic vaccination against CRPV-induced papillomas in HLA-A2.1 transgenic rabbitsHPV16-E7 expression in squamous epithelium creates a local immune suppressive environment via CCL2- and CCL5- mediated recruitment of mast cells.Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasiaCombined treatment of the experimental human papilloma virus-16-positive cervical and head and neck cancers with cisplatin and radioimmunotherapy targeting viral E6 oncoprotein.Dendritic cells and vaccine design for sexually-transmitted diseases.Human papillomaviruses as therapeutic targets in human cancer.Interferon α Induces the Apoptosis of Cervical Cancer HeLa Cells by Activating both the Intrinsic Mitochondrial Pathway and Endoplasmic Reticulum Stress-Induced Pathway.Koch Institute Symposium on Cancer Immunology and ImmunotherapyHuman papillomavirus vaccines in plants.Monitoring of human papillomavirus vaccination.Emerging topics in human tumor virology.Next-generation treatment strategies for human papillomavirus-related head and neck squamous cell carcinoma: where do we go?Human papillomavirus as a target for management, prevention and therapy.Human papillomavirus infection and the risk of cervical cancer in Japan.The potential of plants for the production and delivery of human papillomavirus vaccines.Therapeutic potential of an AcHERV-HPV L1 DNA vaccine.Successful therapeutic vaccination with integrase defective lentiviral vector expressing nononcogenic human papillomavirus E7 protein.Media coverage and public reaction to a celebrity cancer diagnosis.Blocking IL-10 signalling at the time of immunization does not increase unwanted side effects in mice.Non-responders to topical imiquimod followed by vaccination therapy in VIN patients may be due to the level of IL10.Should the treatment paradigms for oral and oropharyngeal cancers be changed now: the role of human papilloma virus?High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.T-Cell Epitope Discovery for Therapeutic Cancer Vaccines.Human papillomavirus prevalence, distribution and correlation to histopathological parameters in a large Swedish cohort of men with penile carcinoma.
P2860
Q26853669-58D58222-125C-428A-9A97-2D0AA39FF20AQ28661746-C9741FF8-558C-47B8-B552-D8D12E161217Q33579159-6FA27D20-EDE2-4CE0-A92A-A73E8F1A9C46Q33618543-D391DC2E-7E8D-4DAD-90FE-350D842EEC30Q34052492-9BD59C53-CFF8-40C3-A293-4E917A625653Q34193431-28A342CB-19CE-4B75-92AF-991EFBFBB896Q34395881-9C371689-3047-41AC-A52B-EAD6562A972AQ35612975-760F5D39-D411-42D2-A38F-F120AFC09665Q36663659-89704195-E99C-4CD0-959E-F69D920D5CD0Q36681262-19ECA394-F842-4B5B-9AA2-7EFDF27FE768Q36910331-2E820AF8-4306-4FA9-96D1-5C9094C97EC9Q37465474-996D04B8-649F-489C-8A53-6F3D41953654Q37500940-1CD9D0FC-16E3-4A2E-AEEE-2A404C222BDDQ37776720-F42EBFDB-9D5E-4C0C-A0AB-18AF1AC1D134Q37808256-1BEBCC8C-6699-46E3-8900-AB0639AEB50BQ37858935-F32CD1AD-03DB-4379-936E-7B365C90A405Q37943790-AC76D140-05CF-4E7F-8E02-3F7C7159B434Q38018120-7AE0BCA4-B05B-449B-8D7D-DF3C223C0007Q38038280-00E0E84C-F455-4594-8D09-8BCCA534E42BQ38424974-73927C7C-5FEB-4A90-A272-BF811E3E0D08Q38869506-4711D4C2-BAD2-40E4-8E51-915D00F0027FQ39330979-153E777F-701D-4682-A923-F4E482373872Q39851098-5E21A91D-71AC-4000-A838-FC80B15004DFQ40082278-25B758AF-5915-41CD-9414-6CE867C4499BQ42426482-0BA87D72-3F90-4CA3-809D-DD066D0FDEB9Q45362182-E52DCA06-B12B-455C-B5B3-65DBC525B7F7Q47136931-86B73418-3F00-45F2-B4A1-0C2D9266478EQ50222492-0E8FBF9D-7408-4C1B-B0F4-42F03C65EE04Q50861629-AF4DBCE7-59D7-48B0-81DC-1AF29496B468Q51745391-25F5C628-79A6-445A-AEF6-D8FC74556129
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Development of therapeutic HPV vaccines.
@ast
Development of therapeutic HPV vaccines.
@en
Development of therapeutic HPV vaccines.
@nl
type
label
Development of therapeutic HPV vaccines.
@ast
Development of therapeutic HPV vaccines.
@en
Development of therapeutic HPV vaccines.
@nl
prefLabel
Development of therapeutic HPV vaccines.
@ast
Development of therapeutic HPV vaccines.
@en
Development of therapeutic HPV vaccines.
@nl
P2860
P1433
P1476
Development of therapeutic HPV vaccines.
@en
P2093
Cornelia L Trimble
P2860
P304
P356
10.1016/S1470-2045(09)70227-X
P50
P577
2009-10-01T00:00:00Z